Abstract
42828 Efficacy and safety of roflumilast cream 0.3% in patients with chronic plaque psoriasis: pooled PASI and PASI-HD results from the DERMIS-1 and DERMIS-2 Phase 3 Trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have